SeaStar Medical Holding
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of SeaStar Medical Holding generated cash of -$10,285,000, which is less than the previous year. Cash used in financing activities reached the amount of $10,414,000 last year. Net change in cash is therefore $129,000.
Cash Flow
| 2020 | -5.57M | 0 | 4.89M |
|---|---|---|---|
| 2021 | -5.11M | -105.57M | 2.81M |
| 2022 | -7.79M | 0 | 7.33M |
| 2023 | -10.28M | 0 | 10.41M |
ICU Cash Flow Statement (2020 – 2023)
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
Cash at beginning of period | 47K | 510K | 2.80M | 3.48M |
Operating activities | ||||
Net income | -26.23M | -23.01M | -4.59M | -3.27M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||
Depreciation and amortization | 0 | 0 | 0 | 0 |
Stock-based compensation expense | 1.93M | 1.31M | 14K | 16 |
| Deferred income tax benefit | 1.93M | 1.31M | 14K | 16 |
| Changes in operating assets and liabilities: | ||||
Accounts receivable, net | 12K | 4K | 0 | 0 |
Inventories | 0 | -4K | 55K | 137K |
Accounts payable | 2.44M | 1.54M | -297K | 225K |
Cash generated by operating activities | -10.28M | -7.79M | -5.11M | -5.57M |
Investing activities | ||||
Purchases Of Investments | 0 | 0 | -105.57M | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 0 | -105.57M | 0 |
Financing activities | ||||
Common Stock Issued | 6.61M | 10.00M | 0 | 25K |
Payments for dividends | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 |
Repayments of term debt | 3.53M | 3.48M | -20K | -300K |
Cash used in financing activities | 10.41M | 7.33M | 2.81M | 4.89M |
Net Change In Cash | 129K | -463K | -2.29M | -680K |
Cash at end of period | 176K | 47K | 510K | 2.80M |
| Data source | Data source |